Congenital diaphragmatic hernia-associated pulmonary hypertension

Farber, 2004, Pulmonary arterial hypertension, N Engl J Med, 351, 1655, 10.1056/NEJMra035488 Lau, 2015, A critical appraisal of the updated 2014 nice pulmonary hypertension classification system, Can J Cardiol, 31, 367, 10.1016/j.cjca.2014.09.033 Abman, 2015, Pediatric pulmonary Hypertension: guidelines from the American heart association and American thoracic society, Circulation, 132, 2037, 10.1161/CIR.0000000000000329 Mohseni-Bod, 2007, Pulmonary hypertension in congenital diaphragmatic hernia, Semin Pediatr Surg, 16, 126, 10.1053/j.sempedsurg.2007.01.008 Pierro, 2014, Understanding and treating pulmonary hypertension in congenital diaphragmatic hernia, Semin Fetal Neonatal Med, 19, 357, 10.1016/j.siny.2014.09.008 Rhinn, 2012, Retinoic acid signalling during development, Development, 139, 843, 10.1242/dev.065938 Zhaorigetu, 2018, Perturbations in endothelial dysfunction-associated pathways in the nitrofen-induced congenital diaphragmatic hernia model, J Vasc Res, 55, 26, 10.1159/000484087 Luong, 2011, Antenatal sildenafil treatment attenuates pulmonary hypertension in experimental congenital diaphragmatic hernia, Circulation, 123, 2120, 10.1161/CIRCULATIONAHA.108.845909 Coppola, 2001, Oxygen-induced vasodilation is blunted in pulmonary arterioles from fetal rats with nitrofen-induced congenital diaphragmatic hernia, J Pediatr Surg, 36, 593, 10.1053/jpsu.2001.22289 Major, 1998, Retinol status of newborn infants with congenital diaphragmatic hernia, Pediatr Surg Int, 13, 547, 10.1007/s003830050399 Beurskens, 2013, Dietary vitamin a intake below the recommended daily intake during pregnancy and the risk of congenital diaphragmatic hernia in the offspring, Birth Defects Res A Clin Mol Teratol, 97, 60, 10.1002/bdra.23093 Shehata, 2006, Pulmonary hypertension in human newborns with congenital diaphragmatic hernia is associated with decreased vascular expression of nitric-oxide synthase, Cell Biochem Biophys, 44, 147, 10.1385/CBB:44:1:147 North, 1995, Pulmonary endothelial nitric oxide synthase gene expression is decreased in a rat model of congenital diaphragmatic hernia, Am J Respir Cell Mol Biol, 13, 676, 10.1165/ajrcmb.13.6.7576705 Sood, 2011, Expression of eNOS in the lungs of neonates with pulmonary hypertension, Exp Mol Pathol, 90, 9, 10.1016/j.yexmp.2010.11.003 Hofmann, 2014, Imbalance of caveolin-1 and eNOS expression in the pulmonary vasculature of experimental diaphragmatic hernia, Birth Defects Res Part B, 101, 341, 10.1002/bdrb.21117 Vukcevic, 2005, Nitrovasodilator responses in pulmonary arterioles from rats with nitrofen-induced congenital diaphragmatic hernia, J Pediatr Surg, 40, 1706, 10.1016/j.jpedsurg.2005.07.004 Putnam, 2016, Evaluation of variability in inhaled nitric oxide use and pulmonary hypertension in patients with congenital diaphragmatic hernia, JAMA Pediatr, 170, 1188, 10.1001/jamapediatrics.2016.2023 Campbell, 2014, Inhaled nitric oxide use in neonates with congenital diaphragmatic hernia, Pediatrics, 134, e420, 10.1542/peds.2013-2644 Galie, 2004, The endothelin system in pulmonary arterial hypertension, Cardiovasc Res, 61, 227, 10.1016/j.cardiores.2003.11.026 Matsumoto, 1989, Abundance of endothelin-3 in rat intestine, pituitary gland and brain, Biochem Biophys Res Commun, 164, 74, 10.1016/0006-291X(89)91684-7 Coppola, 1998, Endothelin-1 pulmonary vasoconstriction in rats with diaphragmatic hernia, J Surg Res, 76, 74, 10.1006/jsre.1997.5293 de Lagausie, 2005, Endothelin receptor expression in human lungs of newborns with congenital diaphragmatic hernia, J Pathol, 205, 112, 10.1002/path.1677 Keller, 2010, Congenital diaphragmatic hernia: endothelin-1, pulmonary hypertension, and disease severity, Am J Respir Crit Care Med, 182, 555, 10.1164/rccm.200907-1126OC Oue, 2002, Increased vascular endothelial growth factor peptide and gene expression in hypoplastic lung in nitrofen induced congenital diaphragmatic hernia in rats, Pediatr Surg Int, 18, 221, 10.1007/s003830100625 Chang, 2004, VEGF expression is downregulated in nitrofen-induced congenital diaphragmatic hernia, J Pediatr Surg, 39, 825, 10.1016/j.jpedsurg.2004.02.015 Sbragia, 2014, VEGF receptor expression decreases during lung development in congenital diaphragmatic hernia induced by nitrofen, Brazil J Med Biol Res, 47, 171, 10.1590/1414-431X20133221 Shehata, 1999, Enhanced expression of vascular endothelial growth factor in lungs of newborn infants with congenital diaphragmatic hernia and pulmonary hypertension, Thorax, 54, 427, 10.1136/thx.54.5.427 Perveen, 2019, MIF inhibition enhances pulmonary angiogenesis and lung development in congenital diaphragmatic hernia, Pediatr Res, 85, 711, 10.1038/s41390-019-0335-6 Herrera-Rivero, 2018, Circulating microRNAs are associated with pulmonary hypertension and development of chronic lung disease in congenital diaphragmatic hernia, Sci Rep, 8, 10735, 10.1038/s41598-018-29153-8 Khoshgoo, 2019, Prenatal microRNA miR-200b therapy improves Nitrofen-induced pulmonary hypoplasia associated with congenital diaphragmatic hernia, Ann Surg, 269, 979, 10.1097/SLA.0000000000002595 Montalva, 2019, Pulmonary hypertension secondary to congenital diaphragmatic hernia: factors and pathways involved in pulmonary vascular remodeling, Pediatr Res, 85, 754, 10.1038/s41390-019-0345-4 Kitagawa, 1971, Lung hypoplasia in congenital diaphragmatic hernia. A quantitative study of airway, artery, and alveolar development, Br J Surg, 58, 342, 10.1002/bjs.1800580507 Levin, 1978, Morphologic analysis of the pulmonary vascular bed in congenital left-sided diaphragmatic hernia, J Pediatr, 92, 805, 10.1016/S0022-3476(78)80162-0 Acker, 2013, Pulmonary artery endothelial cell dysfunction and decreased populations of highly proliferative endothelial cells in experimental congenital diaphragmatic hernia, Am J Physiol Lung Cell Mol Physiol, 305, L943, 10.1152/ajplung.00226.2013 Sluiter, 2013, Premature differentiation of vascular smooth muscle cells in human congenital diaphragmatic hernia, Exp Mol Pathol, 94, 195, 10.1016/j.yexmp.2012.09.010 Mous, 2017, Changes in vasoactive pathways in congenital diaphragmatic hernia associated pulmonary hypertension explain unresponsiveness to pharmacotherapy, Respir Res, 18, 187, 10.1186/s12931-017-0670-2 Aggarwal, 2019, Prognostic utility of noninvasive estimates of pulmonary vascular compliance in neonates with congenital diaphragmatic hernia, J Pediatr Surg, 54, 439, 10.1016/j.jpedsurg.2018.08.057 Sanchez Mejia, 2019, Evaluation and monitoring of pulmonary hypertension in neonates with congenital diaphragmatic hernia, Curr Treat Options Cardiovasc Med, 21, 11, 10.1007/s11936-019-0711-x Hinderliter, 2003, Frequency and severity of tricuspid regurgitation determined by doppler echocardiography in primary pulmonary hypertension, Am J Cardiol, 91, 1033, 10.1016/S0002-9149(03)00136-X King, 1983, Interventricular septal configuration as a predictor of right ventricular systolic hypertension in children: a cross-sectional echocardiographic study, Circulation, 68, 68, 10.1161/01.CIR.68.1.68 Gien, 2016, Management of pulmonary hypertension in infants with congenital diaphragmatic hernia, J Perinatol, 36 Suppl 2, S28, 10.1038/jp.2016.46 Vacanti, 1984, The pulmonary hemodynamic response to perioperative anesthesia in the treatment of high-risk infants with congenital diaphragmatic hernia, J Pediatr Surg, 19, 672, 10.1016/S0022-3468(84)80351-6 Wynn, 2013, Outcomes of congenital diaphragmatic hernia in the modern era of management, J Pediatr, 163, 10.1016/j.jpeds.2012.12.036 Dillon, 2004, The relationship of pulmonary artery pressure and survival in congenital diaphragmatic hernia, J Pediatr Surg, 39, 307, 10.1016/j.jpedsurg.2003.11.010 Finnemore, 2015, Physiology of the fetal and transitional circulation, Semin Fetal Neonatal Med, 20, 210, 10.1016/j.siny.2015.04.003 Hu, 2015, Changes in pulmonary artery pressure during early transitional circulation in healthy full-term newborns, Ultrasonics, 56, 524, 10.1016/j.ultras.2014.10.005 Harting, 2014, The congenital diaphragmatic hernia study group registry update, Semin Fetal Neonatal Med, 19, 370, 10.1016/j.siny.2014.09.004 Hollinger, 2017, Long-term follow-up of congenital diaphragmatic hernia, Semin Pediatr Surg, 26, 178, 10.1053/j.sempedsurg.2017.04.007 Kinsella, 2018, The left ventricle in congenital diaphragmatic Hernia: implications for the management of pulmonary hypertension, J Pediatr, 197, 17, 10.1016/j.jpeds.2018.02.040 Altit, 2018, Diminished cardiac performance and left ventricular dimensions in neonates with congenital diaphragmatic hernia, Pediatr Cardiol, 39, 993, 10.1007/s00246-018-1850-7 Steurer, 2014, B-type natriuretic peptide: prognostic marker in congenital diaphragmatic hernia, Pediatr Res, 76, 549, 10.1038/pr.2014.136 Wong, 2018, Pulmonary hypertension in congenital diaphragmatic hernia patients: prognostic markers and long-term outcomes, J Pediatr Surg, 53, 918, 10.1016/j.jpedsurg.2018.02.015 Hayward, 2007, Predicting inadequate long-term lung development in children with congenital diaphragmatic hernia: an analysis of longitudinal changes in ventilation and perfusion, J Pediatr Surg, 42, 112, 10.1016/j.jpedsurg.2006.09.011 Ichinose, 2004, Inhaled nitric oxide: a selective pulmonary vasodilator: current uses and therapeutic potential, Circulation, 109, 3106, 10.1161/01.CIR.0000134595.80170.62 1997, Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. The neonatal inhaled nitric oxide study group (NINOS), Pediatrics, 99, 838, 10.1542/peds.99.6.838 Kumar, 2018, Response to pulmonary vasodilators in infants with congenital diaphragmatic hernia, Pediatr Surg Int, 34, 735, 10.1007/s00383-018-4286-5 Olson, 2015, Short-Term treprostinil use in infants with congenital diaphragmatic hernia following repair, J Pediatr, 167, 762, 10.1016/j.jpeds.2015.06.016 Skarda, 2015, Epoprostenol does not affect mortality in neonates with congenital diaphragmatic hernia, Eur J Pediatr Surg, 25, 454 Lawrence, 2019, Use of prostaglandin E1 to treat pulmonary hypertension in congenital diaphragmatic hernia, J Pediatr Surg, 54, 55, 10.1016/j.jpedsurg.2018.10.039 Lawrence, 2018, Treprostinil improves persistent pulmonary hypertension associated with congenital diaphragmatic hernia, J Pediatr, 200, 44, 10.1016/j.jpeds.2018.04.052 Lakshminrusimha, 2016, Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide, Semin Perinatol, 40, 160, 10.1053/j.semperi.2015.12.004 Snoek, 2016, Standardized postnatal management of infants with congenital diaphragmatic hernia in Europe: the CDH EURO consortium consensus - 2015 Update, Neonatology, 110, 66, 10.1159/000444210 Mous, 2018, Treatment of rat congenital diaphragmatic hernia with sildenafil and NS-304, selexipag's active compound, at the pseudoglandular stage improves lung vasculature, Am J Physiol, 315, L276 Kipfmueller, 2018, Continuous intravenous sildenafil as an early treatment in neonates with congenital diaphragmatic hernia, Pediatr Pulmonol, 53, 452, 10.1002/ppul.23935 Kraemer, 2018, Characteristics of infants with congenital diaphragmatic hernia who need follow-up of pulmonary hypertension, Pediatr Crit Care Med, 19, e219, 10.1097/PCC.0000000000001464 Pullamsetti, 2014, Novel and emerging therapies for pulmonary hypertension, Am J Respir Crit Care Med, 189, 394, 10.1164/rccm.201308-1543PP Pulido, 2013, Macitentan and morbidity and mortality in pulmonary arterial hypertension, N Engl J Med, 369, 809, 10.1056/NEJMoa1213917 Ghofrani, 2013, Riociguat for the treatment of chronic thromboembolic pulmonary hypertension, N Engl J Med, 369, 319, 10.1056/NEJMoa1209657 Ghofrani, 2013, Riociguat for the treatment of pulmonary arterial hypertension, N Engl J Med, 369, 330, 10.1056/NEJMoa1209655 Beurskens, 2010, Retinol status of newborn infants is associated with congenital diaphragmatic hernia, Pediatrics, 126, 712, 10.1542/peds.2010-0521 Kutasy, 2016, Antenatal retinoic acid administration increases trophoblastic retinol-binding protein dependent retinol transport in the nitrofen model of congenital diaphragmatic hernia, Pediatr Res, 79, 614, 10.1038/pr.2015.256 Pullamsetti, 2012, Role of src tyrosine kinases in experimental pulmonary hypertension, Arterioscler Thromb Vasc Biol, 32, 1354, 10.1161/ATVBAHA.112.248500 Crossno, 2007, Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling, Am J Physiol, 292, L885 Li, 2009, Notch3 signaling promotes the development of pulmonary arterial hypertension, Nat Med, 15, 1289, 10.1038/nm.2021 Savai, 2012, Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension, Am J Respir Crit Care Med, 186, 897, 10.1164/rccm.201202-0335OC Kang, 2015, The therapeutic effects of human mesenchymal stem cells primed with Sphingosine-1 phosphate on pulmonary artery hypertension, Stem Cells Dev, 24, 1658, 10.1089/scd.2014.0496 Curley, 2012, Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat, Thorax, 67, 496, 10.1136/thoraxjnl-2011-201059 Garcia, 2013, Amniotic fluid stem cells inhibit the progression of bleomycin-induced pulmonary fibrosis via CCL2 modulation in bronchoalveolar lavage, PLoS One, 8, e71679, 10.1371/journal.pone.0071679 Wen, 2013, Amniotic fluid stem cells from EGFP transgenic mice attenuate hyperoxia-induced acute lung injury, PLoS One, 8, e75383, 10.1371/journal.pone.0075383 Lee, 2012, Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension, Circulation, 126, 2601, 10.1161/CIRCULATIONAHA.112.114173 Yuniartha, 2014, Therapeutic potential of mesenchymal stem cell transplantation in a nitrofen-induced congenital diaphragmatic hernia rat model, Pediatr Surg Int, 30, 907, 10.1007/s00383-014-3576-9 Granton, 2015, Endothelial NO-Synthase gene-enhanced progenitor cell therapy for pulmonary arterial Hypertension: the PHACeT trial, Circ Res, 117, 645, 10.1161/CIRCRESAHA.114.305951 Gosemann, 2018, Prenatal treatment with rosiglitazone attenuates vascular remodeling and pulmonary monocyte influx in experimental congenital diaphragmatic hernia, PLoS One, 13, 10.1371/journal.pone.0206975 Boston, 2013, Paracorporeal lung assist device: an innovative surgical strategy for bridging to lung transplant in an infant with severe pulmonary hypertension caused by alveolar capillary dysplasia, J Thorac Cardiovasc Surg, 146, e42, 10.1016/j.jtcvs.2013.06.014 Yasufuku, 1998, Arterio-venous extracorporeal membrane oxygenation of fetal goat incubated in artificial amniotic fluid (artificial placenta): influence on lung growth and maturation, J Pediatr Surg, 33, 442, 10.1016/S0022-3468(98)90085-9 Mychaliska, 2016, The artificial placenta: is clinical translation next, Pediatr Pulmonol, 51, 557, 10.1002/ppul.23412 Coughlin, 2018, An artificial placenta protects against lung injury and promotes continued lung development in extremely premature lambs, ASAIO J Oyer, 2004, Reference values for valve circumferences and ventricular wall thicknesses of fetal and neonatal hearts, Pediatr Develop Pathol, 7, 499, 10.1007/s10024-004-1117-6 Bialkowski, 2015, Intravenous sildenafil in the management of pulmonary hypertension associated with congenital diaphragmatic hernia, Eur J Pediatr Surg, 25, 171, 10.1055/s-0033-1357757 Keller, 2004, Treatment of rebound and chronic pulmonary hypertension with oral sildenafil in an infant with congenital diaphragmatic hernia, Pediatr Crit Care Med, 5, 184, 10.1097/01.PCC.0000113266.26638.AD Shiyanagi, 2008, Management of pulmonary hypertension in congenital diaphragmatic hernia: nitric oxide with prostaglandin-E1 versus nitric oxide alone, Pediatr Surg Int, 24, 1101, 10.1007/s00383-008-2225-6 McIntyre, 2013, Safety of epoprostenol and treprostinil in children less than 12 months of age, Pulm Circ, 3, 862, 10.1086/674762